Trastuzumab emtansine - CAS 1018448-65-1

Trastuzumab emtansine (Ado-Trastuzumab emtansine) is an antibody-drug conjugate (ADC) that combines the HER2-targeted antitumor properties of trastuzumab with the cytotoxic activity of DM1, a microtubule-inhibitory derivative of maytansine, and is utilized in the investigation of advanced breast cancer[1][2].

Antibody-Drug Conjugates (ADCs), EGFR

Angiogenesis, Antibody-drug Conjugate/ADC Related, JAK/STAT signaling, Tyrosine Kinase/Adaptors

1018448-65-1

0.98

[Trastuzumab emtansine]

-20°C

Ice Packs

Inhibitory Antibodies